Prashant Kumar

10PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersRadiation and matterMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 26, 2026
Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer.

Janani Sambath, Irene A George, Srikanth S Manda

|Dec 12, 2024
Phosphoproteomics guides low dose drug combination of cisplatin and silmitasertib against concurrent chemoradiation resistant cervical cancer.

Irene A George, Janani Sambath, R E Dhawale

|Jun 17, 2024
Identification of Rare EIF3E::RSPO2 Fusion in Recurrent and Aggressive Urachal Adenocarcinoma.

Prerana Jha, Ruma Pengal, Minit Shah

|Oct 29, 2022
Drug susceptibility testing of circulating lung cancer cells for personalized treatment.

Ajay Balakrishnan, Antony George Francis Thottian, K Govind Babu

|Feb 12, 2022
Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.

Ankit P Jain, Janani Sambath, Gajanan Sathe

|Jan 07, 2022
Reply to S. Cavalieri et al.

Sewanti Limaye, Prashant Kumar, Rajan Datar

Pageof 2

Frequent Collaborators

2 joint publications

Ana Sofia Carvalho

2 joint publications

Rune Matthiesen

1 joint publications

Ankit Jain

1 joint publications

Aditi Chatterjee